for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Bruker Corporation

BRKR.OQ

Latest Trade

48.12USD

Change

0.22(+0.46%)

Volume

123,431

Today's Range

47.45

 - 

48.25

52 Week Range

26.11

 - 

52.08

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

Bruker Reports Q3 GAAP Earnings Per Share Of $0.39

Oct 31 (Reuters) - Bruker Corp <BRKR.O>::BRUKER REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS.Q3 NON-GAAP EARNINGS PER SHARE $0.43.Q3 GAAP EARNINGS PER SHARE $0.39.Q3 REVENUE $521.1 MILLION VERSUS REFINITIV IBES ESTIMATE OF $496.7 MILLION.Q3 EARNINGS PER SHARE ESTIMATE $0.38 -- REFINITIV IBES DATA.SEES FY 2019 NON-GAAP EARNINGS PER SHARE $1.59 TO $1.62.SEES FY 2019 REVENUE UP 7 TO 8 PERCENT.SEES FY 2019 ORGANIC REVENUE GROWTH OF 4.5% TO 5.5%.SEES FY 2019 CONSTANT CURRENCY REVENUE GROWTH OF 10.0% TO 11.0%.CONTINUES TO EXPECT NON-GAAP OPERATING MARGIN EXPANSION IN FY 2019 OF 90 TO 120 BASIS POINTS.RAISING ITS FY 2019 NON-GAAP EPS OUTLOOK TO A RANGE BETWEEN $1.59 AND $1.62.FY2019 EARNINGS PER SHARE VIEW $1.61, REVENUE VIEW $2.04 BILLION -- REFINITIV IBES DATA.

Bruker Announces Acquisition Of Magnettech's EPR Business

Oct 2 (Reuters) - Bruker Corp <BRKR.O>::BRUKER ANNOUNCES ACQUISITION OF MAGNETTECH'S EPR BUSINESS.BRUKER CORP - FINANCIAL DETAILS OF TRANSACTION WERE NOT DISCLOSED..

Bruker Posts Q2 EPS Of $0.23

Aug 1 (Reuters) - Bruker Corp <BRKR.O>::BRUKER REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS.Q2 NON-GAAP EARNINGS PER SHARE $0.33.Q2 GAAP EARNINGS PER SHARE $0.23.Q2 REVENUE $490.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF $477.8 MILLION.SEES FY 2019 REVENUE UP 7 TO 8 PERCENT.Q2 EARNINGS PER SHARE ESTIMATE $0.30 -- REFINITIV IBES DATA.CONFIRMS FY 2019 REVENUE GROWTH, NON-GAAP OPERATING MARGIN EXPANSION AND EARNINGS OUTLOOK.FY2019 EARNINGS PER SHARE VIEW $1.62, REVENUE VIEW $2.04 BILLION -- REFINITIV IBES DATA.

Bruker Comments On Block Trade Transaction

July 17 (Reuters) - Bruker Corp <BRKR.O>::BRUKER COMMENTS ON BLOCK TRADE TRANSACTION.BRUKER CORP - JOERG LAUKIEN RETIRED FROM BRUKER BOARD OF DIRECTORS EFFECTIVE NOVEMBER 5, 2018.BRUKER CORP - ADVISED THAT FORMER BOARD MEMBER, MR. JOERG C. LAUKIEN, HAS AUTHORIZED A BLOCK SALE OF BRUKER SHARES AS PART OF HIS RETIREMENT PLANNING.BRUKER CORP - JOERG LAUKIEN IS BROTHER OF CEO WHO IS NOT SELLING ANY SHARES IN THIS TRANSACTION..

Bruker And Champalimaud Foundation Collaborate To Develop Novel Ultra-High Field 18 Tesla Preclinical MRI System and Applications

May 13 (Reuters) - Bruker Corp <BRKR.O>::BRUKER AND CHAMPALIMAUD FOUNDATION ANNOUNCE COLLABORATION TO DEVELOP NOVEL ULTRA-HIGH FIELD 18 TESLA PRECLINICAL MRI SYSTEM AND APPLICATIONS.BRUKER CORP - 18T MRI IS EXPECTED TO BE INSTALLED IN LATE 2021 IN NEUROPLASTICITY AND NEURAL ACTIVITY LABORATORY.

Bruker Announces New $300 Million Share Repurchase Authorization And Quarterly Dividend

May 10 (Reuters) - Bruker Corp <BRKR.O>::BRUKER ANNOUNCES NEW $300 MILLION SHARE REPURCHASE AUTHORIZATION AND QUARTERLY DIVIDEND.BRUKER CORP - APPROVED $300 MILLION SHARE REPURCHASE OVER A TWO-YEAR PERIOD COMMENCING MAY 14, 2019.BRUKER CORP - INTENDS TO FUND REPURCHASES FROM CASH ON HAND, AVAILABLE BORROWINGS UNDER ITS EXISTING CREDIT FACILITY.

Bruker Reports Q1 Non-GAAP Earnings Per Share $0.28

May 2 (Reuters) - Bruker Corp <BRKR.O>::BRUKER REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 NON-GAAP EARNINGS PER SHARE $0.28.Q1 GAAP EARNINGS PER SHARE $0.20.Q1 REVENUE $461.4 MILLION VERSUS REFINITIV IBES ESTIMATE OF $450.1 MILLION.Q1 EARNINGS PER SHARE ESTIMATE $0.24 -- REFINITIV IBES DATA.RAISING FULL YEAR GUIDANCE FOR REVENUE GROWTH AND EARNINGS.SEES FY ORGANIC REVENUE GROWTH OF 4.5% TO 5.5%;.SEES FY CONSTANT CURRENCY REVENUE GROWTH OF 9.5% TO 10.5%;.SEES FY NON-GAAP OPERATING MARGIN EXPANSION OF 90 BPS TO 120 BPS.SEES FY NON-GAAP EPS OF $1.57 TO $1.61.FY2019 EARNINGS PER SHARE VIEW $1.57, REVENUE VIEW $2.02 BILLION -- REFINITIV IBES DATA.

Bruker Q4 GAAP Earnings Per Share $0.50

Feb 11 (Reuters) - Bruker Corp <BRKR.O>::BRUKER REPORTS FOURTH QUARTER AND FISCAL YEAR 2018 FINANCIAL RESULTS.Q4 NON-GAAP EARNINGS PER SHARE $0.54.Q4 GAAP EARNINGS PER SHARE $0.50.Q4 REVENUE $553.6 MILLION VERSUS REFINITIV IBES ESTIMATE OF $544.6 MILLION.Q4 EARNINGS PER SHARE ESTIMATE $0.54 -- REFINITIV IBES DATA.SEES FY 2019 NON-GAAP EARNINGS PER SHARE $1.54 TO $1.58.SEES FY 2019 REVENUE UP 6 TO 7 PERCENT.FOR FY 2019, SEES ORGANIC REVENUE GROWTH OF 4% TO 5%.SEES NEGATIVE FOREIGN CURRENCY TRANSLATION EFFECT ON REVENUE OF 2% IN 2019.EXPECTS AN INCREASE IN FY 2019 NON-GAAP OPERATING MARGIN OF 70 BPS TO 100 BPS YEAR-OVER-YEAR FROM 16.8% IN FY 2018.FY2019 REVENUE VIEW $1.97 BILLION -- REFINITIV IBES DATA.

Bruker Announces Agreement To Acquire Majority In Hain Lifescience GmbH

Aug 24 (Reuters) - Bruker Corp <BRKR.O>::BRUKER ANNOUNCES AGREEMENT TO ACQUIRE MAJORITY IN INFECTIOUS DISEASE-FOCUSED MOLECULAR DIAGNOSTICS (MDX) COMPANY HAIN LIFESCIENCE GMBH.EXPECTS TO ACQUIRE AN 80% MAJORITY INTEREST IN HAIN, WITH OPTIONS FOR REMAINING 20% THAT CAN BE EXERCISED AFTER 2021.IN 2018 HAIN EXPECTS TO GENERATE REVENUES OF ABOUT $38 MILLION.FINANCIAL DETAILS OF THE DEAL WERE NOT DISCLOSED.EXPECTS HAIN TO CONTINUE DOING BUSINESS AS 'BRUKER-HAIN DIAGNOSTICS'.BRUKER INTENDS TO RETAIN ESSENTIALLY ALL HAIN EMPLOYEES AND HAIN RESEARCH AND DEVELOPMENT, MANUFACTURING AND DISTRIBUTION CAPABILITIES.IN 2019, BRUKER ANTICIPATES TRANSACTION TO BE ACCRETIVE TO BRUKER'S NON-GAAP EPS BY $0.01-$0.02.DOES NOT EXPECT DEAL TO HAVE ANY MATERIAL IMPACT ON BRUKER'S 2018 NON-GAAP OPERATING MARGIN EXPANSION AND EPS GUIDANCE.

Bruker Q2 Non-GAAP Earnings Per Share $0.25

Bruker Corp <BRKR.O>::BRUKER REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 NON-GAAP EARNINGS PER SHARE $0.25.Q2 GAAP EARNINGS PER SHARE $0.20.Q2 REVENUE $443.7 MILLION VERSUS I/B/E/S VIEW $436.9 MILLION.SEES FY 2018 NON-GAAP EARNINGS PER SHARE $1.34 TO $1.38.SEES FY 2018 REVENUE UP ABOUT 6.5 PERCENT.Q2 EARNINGS PER SHARE VIEW $0.25 -- THOMSON REUTERS I/B/E/S.FY2018 EARNINGS PER SHARE VIEW $1.38, REVENUE VIEW $1.88 BILLION -- THOMSON REUTERS I/B/E/S.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up